Ursolic acid attenuates cholestasis through NRF2-mediated regulation of UGT2B7 and BSEP/MRP2

A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

Kris V. Kowdley, Velimir A. Luketic, Roger W. Chapman et al. · Hepatology · 2017 · 277 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Maren H. Harms, Henk R. van Buuren, Christophe Corpechot et al. · Journal of Hepatology · 2019 · 277 citations · Full text

Medicine, Internal Medicine, Surgery +9

Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway

Yan Ding, Lei Zhao, Hong Mei et al. · European Journal of Pharmacology · 2008 · 141 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Comparative analysis of 3D culture methods on human HepG2 cells

Claudia Luckert, Christina Schulz, Nadja Lehmann et al. · Archives of Toxicology · 2016 · 111 citations

Life Sciences, Cell Biology, Cell Differentiation +13

Protective role of luteolin against bisphenol A‐induced renal toxicity through suppressing oxidative stress, inflammation, and upregulating Nrf2/ARE/ HO‐1 pathway

Gadamsetty Jaya Alekhya Sita, M Gowthami, Gadiparthi Srikanth et al. · IUBMB Life · 2019 · 98 citations · Full text

Medicine, Pharmacology, Toxicology +16